Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · IEX Real-Time Price · USD

2.380

-0.170 (-6.67%)

At close: Jul 2, 2024, 4:00 PM

2.480

+0.100 (4.20%)

After-hours: Jul 2, 2024, 7:34 PM EDT

Cellectar Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2004
Market Capitalization	85	34	16	41	56	21	Upgrade
Market Cap Growth	821.80%	112.09%	-60.44%	-27.26%	163.81%	186.68%	Upgrade
Enterprise Value	46	25	-3	5	-1	11	Upgrade
PE Ratio	-	-0.90	-0.56	-1.68	-3.69	-1.50	Upgrade
PB Ratio	3.26	-25.10	1.03	1.23	1.02	2.33	Upgrade
P/FCF Ratio	-3.26	-1.02	-0.63	-1.79	-3.99	-1.80	Upgrade
P/OCF Ratio	-3.33	-1.05	-0.64	-1.80	-4.00	-1.81	Upgrade
EV/EBITDA Ratio	-1.75	-0.66	0.11	-0.22	0.07	-0.80	Upgrade
EV/EBIT Ratio	-1.74	-0.66	0.11	-0.21	0.06	-0.78	Upgrade
EV/FCF Ratio	-2.25	-0.75	0.13	-0.23	0.07	-0.94	Upgrade
Debt / Equity Ratio	0.02	-0.41	0.04	0.01	0.01	0.06	Upgrade
Debt / EBITDA Ratio	-0.01	-0.01	-0.02	-0.01	-0.03	-0.04	Upgrade
Debt / FCF Ratio	-0.01	-0.02	-0.02	-0.01	-0.03	-0.05	Upgrade
Quick Ratio	2.46	0.74	3.59	8.95	16.04	3.83	Upgrade
Current Ratio	2.54	0.81	3.71	9.16	16.26	4.11	Upgrade
Return on Equity (ROE)	-1855.60%	1937.60%	-151.20%	-58.30%	-62.70%	-119.60%	Upgrade
Return on Assets (ROA)	-245.60%	-276.40%	-115.80%	-53.00%	-54.00%	-94.60%	Upgrade
Return on Capital (ROIC)	-158.18%	4851.49%	-178.84%	-72.36%	-27.69%	-147.90%	Upgrade
Earnings Yield	-59.76%	-111.59%	-178.21%	-59.46%	-27.06%	-66.66%	Upgrade
FCF Yield	-46.23%	-97.66%	-158.57%	-55.98%	-25.09%	-55.43%	Upgrade
Buyback Yield / Dilution	-160.60%	-73.22%	-27.09%	-180.20%	-158.14%	-159.12%	Upgrade
Total Shareholder Return	-160.60%	-73.22%	-27.09%	-180.20%	-158.14%	-159.12%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).